Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews

BACKGROUND: There is conflicting evidence on the association between antipsychotic polypharmacy and metabolic syndrome in schizophrenia. We conducted a review of published systematic reviews to evaluate evidence on the association between metabolic syndrome (diabetes, hypertension, and hyperlipidaem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ijaz, Sharea, Bolea, Blanca, Davies, Simon, Savović, Jelena, Richards, Alison, Sullivan, Sarah, Moran, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122457/
https://www.ncbi.nlm.nih.gov/pubmed/30176844
http://dx.doi.org/10.1186/s12888-018-1848-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122457/
https://www.ncbi.nlm.nih.gov/pubmed/30176844
http://dx.doi.org/10.1186/s12888-018-1848-y

Ejemplares similares